(单词翻译:单击)
Researchers report that a drug commonly used to treat diabetes1 may also retard2(延迟,阻止) the growth of fluid-filled cysts(囊肿) of the most common genetic3 disorder4, polycystic kidney(多囊肾) disease. PKD does not discriminate5 by gender6 or race and affects one in 1,000 adults worldwide. Researchers from the schools of Science and Medicine at Indiana University-Purdue University Indianapolis and colleagues from the Mayo Clinic report this month in the online peer-reviewed journal PPAR Research that pioglitazone appears to control the growth of PKD cysts.
Using a rat model that has the same genetic mutation7 as a form of human PKD, the two research groups independently tested a pioglitazone treatment regimen and found that it slowed down both kidney and liver cyst growth by inhibiting8 a chloride(氯化物) channel in the cells of these organs.
Normally pioglitazone works by making the body more sensitive to its own insulin. However, in studying why this class of drugs causes fluid retention9, Bonnie L. Blazer-Yost, Ph.D., professor of biology at the IUPUI School of Science and corresponding author of the new study, serendipitously10(意外收获) found that it also inhibits11 a chloride channel.
"We thought that since this class of drugs inhibits the body's chloride channels, then it would be a good candidate to treat PKD, a disease in which excessive chloride and water are transported into the cysts of the kidneys and the liver causing them to expand," said Blazer-Yost, Ph.D.
A normal kidney is the size of a fist. A polycystic kidney is the size of a football. Currently there is no cure for PKD and therapy options are limited. Organ transplantation is the most common treatment.
"The idea of using a chloride channel inhibitor to treat PKD is not new. What is new is our finding that an insulin sensitizing agent like piogltiazone inhibits chloride channels. The finding that pioglitazone, which has already been approved by the Food and Drug Administration for diabetes, can halt cyst progression and may be an effective and well-tolerated treatment for this chronic12 disease, is exciting. Confirmation13 of these results in other animal models of PKD would be a useful next step.
"We know from long-term experience that this drug has a good safety profile. Strategies that minimize adverse14 events are important when considering treatments for a chronic disease such as PKD," said Blazer-Yost, a physiologist15 who hopes that human trials of pioglitazone therapy for PKD can be conducted in the near future.
收听单词发音
1
diabetes
|
|
| n.糖尿病 | |
参考例句: |
|
|
|
2
retard
|
|
| n.阻止,延迟;vt.妨碍,延迟,使减速 | |
参考例句: |
|
|
|
3
genetic
|
|
| adj.遗传的,遗传学的 | |
参考例句: |
|
|
|
4
disorder
|
|
| n.紊乱,混乱;骚动,骚乱;疾病,失调 | |
参考例句: |
|
|
|
5
discriminate
|
|
| v.区别,辨别,区分;有区别地对待 | |
参考例句: |
|
|
|
6
gender
|
|
| n.(生理上的)性,(名词、代词等的)性 | |
参考例句: |
|
|
|
7
mutation
|
|
| n.变化,变异,转变 | |
参考例句: |
|
|
|
8
inhibiting
|
|
| 抑制作用的,约束的 | |
参考例句: |
|
|
|
9
retention
|
|
| n.保留,保持,保持力,记忆力 | |
参考例句: |
|
|
|
10
serendipitously
|
|
| 偶然发现的 | |
参考例句: |
|
|
|
11
inhibits
|
|
| 阻止,抑制( inhibit的第三人称单数 ); 使拘束,使尴尬 | |
参考例句: |
|
|
|
12
chronic
|
|
| adj.(疾病)长期未愈的,慢性的;极坏的 | |
参考例句: |
|
|
|
13
confirmation
|
|
| n.证实,确认,批准 | |
参考例句: |
|
|
|
14
adverse
|
|
| adj.不利的;有害的;敌对的,不友好的 | |
参考例句: |
|
|
|
15
physiologist
|
|
| n.生理学家 | |
参考例句: |
|
|
|